AstraZeneca

When Graham Caveney was diagnosed with stage-four oesophageal cancer in 2022, doctors gave him just over a year…

Inside the DIY Ozempic boom Americans are cooking up their own Ozempic—here’s why that’s alarming. Jess Loren remembers…

US President Donald Trump on Friday announced reaching a deal with AstraZeneca, which would lower the cost of…

Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…

Image source: Getty Images The pharmaceuticals sector used to be a happy hunting ground for investors looking for income…

World shares advanced on Monday, extending September’s rally in a session that finished on a note of caution…

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…

AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult…

By Alistair Smout and Sarah Young LONDON (Reuters) -Britain defended its record on attracting investment on Thursday after…

Hundreds of deaths have been linked to powerful antidepressants, figures show. None of the fatalities, however, are proven…

Graham put his pain down to acid reflux then doctors told him it was cancer and he had a year to live. Now thanks to an astonishing new drug his tumour has halved and it’s helping breast cancer patients too. His doctor says: ‘It’s so exciting!’